![]() |
市场调查报告书
商品编码
1766078
2032 年宠物 DNA 检测市场预测:按动物类型、检测类型、样本类型、分销管道、最终用户和地区进行的全球分析Pet DNA Testing Market Forecasts to 2032 - Global Analysis By Animal Type (Dogs, Cats, Horses, Birds and Other Animal Types), Test Type, Sample Type, Distribution Channel, End User and By Geography |
根据 Stratistics MRC 的数据,全球宠物 DNA 检测市场预计在 2025 年达到 4.561 亿美元,预测期内的复合年增长率为 12.3%,到 2032 年将达到 10.273 亿美元。宠物 DNA 检测是一种透过唾液或颊拭子样本分析动物(主要是狗和猫)基因组成的科学方法。此测试有助于识别宠物的品种组成、血统、遗传特征和潜在的遗传健康风险。解码宠物的 DNA 可以让饲主了解行为倾向、预测体型和某些疾病的易患性。兽医和饲主可以使用这些资讯在医疗保健、营养和训练方面做出明智的决定。随着宠物变得越来越人性化,DNA 检测正成为一种越来越受欢迎的工具,以提高宠物护理和健康的品质。
根据FEDIAF 2024报告,预计2023年宠物相关产品和服务的销售额将达到274.5亿美元,大幅高于去年。
提高宠物拥有率和人性化
宠物拥有率的上升以及宠物人性化趋势的日益增长,极大地推动了宠物DNA检测市场的发展。随着越来越多的人将宠物视为家庭的一部分,越来越多的人开始投资先进的医疗保健解决方案,包括基因检测,以确保宠物的健康。宠物饲主对宠物的血统、品种、健康倾向和特征越来越感兴趣,这刺激了对DNA检测服务的需求。这种情感和预防性医疗保健的连结正推动市场参与企业创新和扩展其服务,从而促进市场成长。
对准确性和可靠性的担忧
对准确性和可靠性的担忧正在对宠物DNA检测市场的成长产生负面影响。检测结果不一致以及不同检测机构之间缺乏标准化,降低了消费者的信任度,并限制了其应用。宠物饲主可能会怀疑宠物健康状况和品种报告的有效性,尤其是在不同的检测结果相互矛盾时。这种疑虑阻碍了广泛的信任,尤其是在依赖准确基因资讯取得的兽医和繁殖者群体中,从而减缓了市场扩张。
提高健康意识
宠物饲主日益增强的健康意识推动了宠物DNA检测市场的发展。随着人们开始将宠物视为家庭成员,他们开始对了解宠物的基因组成感兴趣,以便主动管理宠物的健康问题、营养需求和特定品种的疾病。这种观念的转变推动了DNA检测套组的使用,以确保宠物的长期健康和预防性医疗保健。这一趋势也与日益增长的个人化宠物护理解决方案需求相契合,进一步推动了市场扩张。
高成本且可近性有限
高昂的成本和有限的可及性阻碍了宠物DNA检测市场的扩张。许多宠物饲主,尤其是低度开发国家的饲主,无法负担检测套组和服务的费用。此外,在服务匮乏的地区和农村地区,检测服务有限,限制了消费者的取得。随着人们对宠物健康和基因洞察的兴趣日益浓厚,这些因素共同限制了市场渗透,降低了需求,并减缓了普及速度。
COVID-19的影响
新冠疫情对宠物DNA检测市场产生了多方面的影响。虽然早期疫情中断影响了供应链并延误了非必要的兽医服务,但疫情期间宠物领养数量的增加显着提升了对居家宠物护理解决方案(包括DNA检测套组)的需求。疫情期间,消费者对宠物健康和保健的关注度不断提高,进一步激发了消费者的兴趣,从而提升了宠物基因检测提供者的知名度,并带来了新的成长机会。
预计品种辨识领域在预测期内将成长至最大
宠物饲主日益增长的好奇心以及对个人化护理的需求预计将使品种识别细分市场在预测期内占据最大的市场占有率。识别宠物的品种可以提升宠物的健康水平,使它们能够获得量身定制的营养、训练和医疗保健。该细分市场还能帮助收养饲主主人提供更详细的信息,从而促进领养。随着宠物人性化趋势的持续,人们对了解品种特定特征的渴望正在推动DNA检测的需求,使犬种识别成为市场的核心收益因素。
预计预测期内,颊拭子部分将以最高复合年增长率成长
在预测期内,颊拭子市场预计将实现最高成长率,因为它是一种简单、非侵入性且宠物友善的采样技术。口腔拭子更受宠物饲主的青睐,因为它可以在家中轻鬆采集DNA,减轻饲主和宠物的压力。由于其便利性,它也越来越受到消费者和兽医诊所的青睐。此外,颊拭子能够确保遗传物质的准确采集,进而提高检测结果的可靠性,进而增加对宠物DNA检测服务的需求。
在预测期内,亚太地区预计将占据最大的市场占有率,这得益于宠物拥有率的上升、可支配收入的增加以及人们对宠物健康和遗传学的认识的不断提高。宠物的都市化和人性化正在鼓励饲主投资先进的诊断技术,例如用于品种识别、健康检查和血统追踪的DNA检测。此外,兽医基础设施的不断扩展和创新检测套组的普及也推动了市场需求,使亚太地区成为全球格局的关键成长区域。
预计北美地区在预测期内将实现最高的复合年增长率。这得益于宠物拥有量的增加以及对动物遗传学和健康知识的不断加深。消费者正在主动了解宠物的品种、健康风险和血统。高可支配收入和先进的兽医基础设施推动了此类诊断方法的普及。此外,宠物日益人性化也推动了对个人化宠物护理产品的需求,这是北美市场成长的主要驱动力。
According to Stratistics MRC, the Global Pet DNA Testing Market is accounted for $456.1 million in 2025 and is expected to reach $1027.3 million by 2032 growing at a CAGR of 12.3% during the forecast period. Pet DNA testing is a scientific method used to analyze the genetic makeup of animals, primarily dogs and cats, through a sample of saliva or cheek swab. This test helps identify the breed composition, ancestry, inherited traits, and potential genetic health risks of a pet. By decoding the pet's DNA, owners can gain insights into behavior tendencies, size predictions, and predispositions to certain diseases. Veterinarians and pet owners use this information to make informed decisions about healthcare, nutrition, and training. As pet humanization rises, DNA testing has become an increasingly popular tool for improving the quality of pet care and well-being.
According to the FEDIAF 2024 report, pet-related products and services sales reached USD 27.45 billion in 2023, a significant rise over the prior year.
Rising Pet Ownership & Humanization
Rising pet ownership and the growing trend of pet humanization are significantly driving the Pet DNA Testing Market. As more individuals consider pets as family members, they are increasingly investing in advanced healthcare solutions, including genetic testing, to ensure their pets' well-being. Pet owners are becoming more curious about their pets' ancestry, breed, health predispositions, and traits, fueling demand for DNA testing services. This emotional and preventive healthcare connection is pushing market players to innovate and expand their offerings, boosting market growth.
Accuracy & Reliability Concerns
Accuracy and reliability concerns are negatively impacting the growth of the Pet DNA Testing Market. Inconsistent results and lack of standardization among different testing providers reduce consumer confidence and limit adoption. Pet owners may question the validity of health or breed reports, especially when different tests yield conflicting information. These doubts hinder widespread trust and slow market expansion, especially among veterinarians and breeders who rely on precise genetic insights.
Growing Health & Wellness Awareness
The Pet DNA Testing Market is being driven favourably by increasing health and wellness awareness among pet owners. People are becoming more interested in knowing their pets' genetic composition in order to proactively manage health concerns, nutritional requirements, and breed-specific diseases as they treat pets more like members of the family. This change in perspective promotes the use of DNA testing kits to guarantee long-term health and preventive care. The trend is also in line with the growing need for individualized pet care solutions, which is further accelerating market expansion.
High Costs & Limited Accessibility
High costs and limited accessibility stymie the expansion of the Pet DNA Testing Market. Many pet owners, particularly those in underdeveloped nations, cannot afford the cost of testing kits and services. Additionally, consumer access is restricted by limited availability in underserved or rural locations. Even while interest in pet health and genetic insights is growing, these constraints taken together limit market penetration, reducing demand and slowing adoption.
Covid-19 Impact
The Covid-19 pandemic had a mixed impact on the Pet DNA Testing Market. While initial disruptions affected supply chains and delayed non-essential veterinary services, the rise in pet adoptions during lockdowns significantly boosted demand for at-home pet care solutions, including DNA testing kits. Increased focus on pet health and wellness during the pandemic further fueled consumer interest, leading to greater awareness and growth opportunities for pet genetic testing providers.
The breed identification segment is expected to be the largest during the forecast period
The breed identification segment is expected to account for the largest market share during the forecast period, due to rising pet owner curiosity and demand for personalized care. Identifying a pet's breed enables tailored nutrition, training, and health management, enhancing pet well-being. This segment also supports adoption efforts by helping shelters provide potential owners with more detailed information. As pet humanization trends continue, the desire for understanding breed-specific traits fuels the demand for DNA testing, making breed identification a central revenue-generating component of the market.
The buccal swab segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the buccal swab segment is predicted to witness the highest growth rate, because of its simple, non-invasive, and pet-friendly sampling technique. Buccal swabs are preferred by pet owners because they make it possible to collect DNA at home painlessly, which lessens stress for both owners and pets. Customers and veterinary clinics have adopted it more frequently as a result of its convenience. Furthermore, buccal swabs guarantee precise genetic material collection, which improves test result reliability and increases demand for pet DNA testing services.
During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to rising pet adoption rates, increasing disposable income, and growing awareness of pet health and genetics. Urbanization and the humanization of pets are encouraging owners to invest in advanced diagnostics like DNA testing for breed identification, health screening, and ancestry tracking. Additionally, expanding veterinary infrastructure and the availability of innovative testing kits are driving market demand, making Asia Pacific a key growth region in the global landscape.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because more people keep pets and are more knowledgeable about the genetics and health of animals. Customers are taking the initiative to learn more about the breed, health hazards, and ancestry of their pets. High disposable incomes and sophisticated veterinary infrastructure encourage the use of these diagnostics. Additionally, as pets become more humanized, there is a greater need for individualized pet care products, which makes North America a major driver of the market's growth.
Key players in the market
Some of the key players profiled in the Pet DNA Testing Market include Mars Incorporated, Zoetis Inc., Embark Veterinary Inc., Neogen Corporation, Macrogen Inc., EasyDNA, Orivet Genetic Pet Care LLC, DNA MY DOG Inc., Animal Genetics Inc., GenSol Diagnostics LLC, FamilyTreeDNA, AncestryDNA Inc., Urban Animal Inc., Control Genetics, OptiGen, VetGen, HealthGene, Paw Print Genetics and Canine HealthCheck.
In August 2024, Mars, Incorporated and Kellanova announced that they have entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash, for a total consideration of $35.9 billion, including assumed net leverage.
In October 2022, Accenture is working with Mars, the global leader in confectionary, food, and pet care products and services, to transform and modernize its global manufacturing operations with artificial intelligence (AI), cloud, edge technology and digital twins.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.